All News
The pharma industry’s silence on RFK Jr., and efforts by parents to develop gene therapies for their children
STAT reporters discuss why drugmakers have not lobbied against RFK Jr.'s nomination to lead HHS and the struggles around developing gene therapies.
Read MoreLung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk Patients
(MedPage Today) -- The non-small cell lung cancer (NSCLC) drug osimertinib (Tagrisso) was associated with an increased risk of therapy-related cardiovascular (CV) events compared with older EGFR inhi
Read MoreSTAT+: Investors in Padlock Therapeutics sue Bristol Myers Squibb over ‘milestone’ payments
Investors in Padlock Therapeutics have accused Bristol Myers Squibb of reneging on payments of up to $450 million negotiated as part of a 2016 acquisition agreement.
Read MoreSTAT+: How RFK Jr. could impact addiction treatment
This week in health policy and politics news: What RFK Jr. could mean for addiction treatment and analyzing a bill to take on PBMs.
Read MoreDoc Confesses to Killing Wife, Police Say; Nurse Reprimanded for Cursing at Toddler
(MedPage Today) -- Orlando-area physician Thomas Wentzell, MD, was arrested and confessed to killing his wife, according to local police.
Read MoreWatch: ‘Going It Alone’ — A Conversation About Growing Old in America
Judith Graham, KFF Health News' "Navigating Aging" columnist, talks with older adults who live alone by choice or circumstance. They share what it means to thrive in later years.
Read MoreThe 7 Biggest Financial Enemies of Doctors
(MedPage Today) -- Success in personal finance and reaching financial freedom is not complicated. But that does not mean it is necessarily easy -- especially for doctors.
Read MoreSubcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
(MedPage Today) -- One of the most meaningful shifts in the cancer treatment landscape has been the move toward therapies that not only fight the disease, but also empower patients and healthcare pro
Read MoreFDA Issues Safety Alert on Liver Disease Drug
(MedPage Today) -- Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis (PBC) patients without cirrhosis, the FDA said in a safet
Read MoreProviders, You Are the Missing Piece: Your Patients With OUD Need You
(MedPage Today) -- As of 2023, more than 5 million people ages 12 or older in the U.S. have opioid use disorder (OUD).
Read More